Pulse lineResearch With Heart Logo

Coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease.

TitleCoagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin and risk of coronary heart disease.
Publication TypeJournal Article
Year of Publication2010
AuthorsYamagishi K, Aleksic N, Hannan PJ, Folsom AR
Corporate AuthorsARIC Study Inverstigators
JournalJ Atheroscler Thromb
Volume17
Issue4
Pagination402-9
Date Published2010 Apr 30
ISSN1880-3873
Keywordsalpha-2-Antiplasmin, Blood Coagulation Factors, Case-Control Studies, Coronary Disease, Factor IX, Factor V, Factor X, Factor XI, Factor XII, Female, Humans, Male, Middle Aged, Plasminogen, Prospective Studies, Prothrombin, Risk Factors
Abstract

AIM: To examine whether plasma levels of coagulation factors II, V, IX, X, XI, and XII, plasminogen, and alpha-2 antiplasmin are associated with coronary heart disease (CHD) in a prospective case-cohort study.

METHODS: This case-cohort sample consisted of 368 African-Americans or whites with incident CHD that occurred between 1990-92 and 1998, from the Atherosclerosis Risk in Communities (ARIC) study, and a cohort random sample of n=412. Hemostatic factors were measured in the case-cohort sample using plasma stored at -70 degrees C since 1990-92.

RESULTS: After adjustments for age, sex and race, coagulation factors IX and XI, and alpha-2 antiplasmin were associated positively with risk of CHD: The hazard ratio [95% confidence interval] for the highest vs lowest quartiles was 1.52 [1.01-2.27] for factor IX; 2.26 [1.47-3.48] for factor XI; and 1.64 [1.05-2.57] for alpha-2 antiplasmin. However, as these hemostatic factors were correlated with classical risk factors, their association with CHD was attenuated and no longer statistically significant after multivariable adjustments. No association was observed between CHD and factor II, V, X, or XII, or plasminogen.

CONCLUSIONS: Positive associations of factors IX and XI, and alpha-2 antiplasmin with incident CHD were not strong and accounted for by classical coronary risk factors.

DOI10.5551/jat.3673
Alternate JournalJ Atheroscler Thromb
PubMed ID20379055
PubMed Central IDPMC2866762
Grant ListN01-HC55021 / HC / NHLBI NIH HHS / United States
N01-HC55015 / HC / NHLBI NIH HHS / United States
N01-HC55022 / HC / NHLBI NIH HHS / United States
N01HC55015 / HL / NHLBI NIH HHS / United States
N01-HC55019 / HC / NHLBI NIH HHS / United States
N01 HC055019 / HC / NHLBI NIH HHS / United States
N01-HC55018 / HC / NHLBI NIH HHS / United States
N01-HC55016 / HC / NHLBI NIH HHS / United States
N01-HC55020 / HC / NHLBI NIH HHS / United States